Most clinics find out a patient is leaving when they cancel — the last event, not the first. ProtocolIQ flags them weeks earlier, tracking every protocol automatically: who's overdue, how they're tolerating their dose, and whether they're actually losing weight.
SMS-first · No patient app · Sits on top of your EMR
What your team sees every morning
Denise A.
Tirzepatide · Week 9 of 20
reported struggling · 12d overdue
Ray C.
Semaglutide · Week 6 of 16
follow-up due · 8d overdue
Priya R.
Semaglutide · Week 4 of 16
mild side effects · 4d overdue
64.8%
adults on GLP-1 for weight loss stop within their first year
JAMA Network Open, Jan 2025 · 125,474 US adults
Weeks
earlier you spot a patient slipping — not after they cancel
1 tap
for patients to reply — no app, no login, no portal
SMS-first
No portal, no friction
No patient app
One tap to reply
Sits on your EMR
No double entry
Built to scale
Grows with your clinic
How it works
No new software for your patients, no extra work for your staff. It runs quietly on top of what you already do.
Each patient gets a text anchored to their current dose. One tap to reply — no app, no login, no friction.
Every reply updates a green/yellow/red status. Dose tolerance, weight, and silence roll into one risk score.
Slipping patients surface at the top, ranked by urgency with the reason — so your team acts before they cancel.
The invisible churn
Overdue patients are easy to spot. The dangerous ones still look on-track — until they're gone. ProtocolIQ watches the quiet signals and surfaces them in one “Needs attention today” list, so you reach out before they cancel, not after.
Signals we watch
Replied “struggling”
Side effects with no one to guide them — a leading reason patients quit.
Weight plateaued
Progress stalls, motivation fades.
Gone quiet 10+ days
No reply, no dose confirmation.
Dose slipped
Overdue and drifting off protocol.
Why patients really leave
Patients don't quit because the medication stops working. They quit when they lose trust, hit side effects with no one to guide them, or plateau — and no one notices in time.
ProtocolIQ is the layer that catches that moment: the check-in, the signal, the nudge to reach out — so support arrives while the patient is still on the fence.
Positioning
ProtocolIQ doesn't replace your EMR, your pharmacy, or your shipping. It sits on top of what you already run and watches the one thing nothing else does — whether the patient is still with you. A missed dose tells you more than a delivery confirmation ever will.
Sample data — no login required. The roster sorts so the patients slipping sit right at the top.
Your clinic's patients, sorted by next injection.
0
0
0
0
Denise A.
Tirzepatide · Week 9 of 20
reported struggling · 12d overdue
Ray C.
Semaglutide · Week 6 of 16
follow-up due · 8d overdue
Priya R.
Semaglutide · Week 4 of 16
mild side effects · 4d overdue
Full roster
| Patient | Protocol | Progress | Dose | Next injection | Status |
|---|---|---|---|---|---|
| Denise A. | Tirzepatide | Week 9 of 20 | 5 mg | Aug 30, 2026 12d overdue | Overdue |
| Ray C. | Semaglutide | Week 6 of 16 | 1 mg | Sep 3, 2026 8d overdue | Overdue |
| Priya R. | Semaglutide | Week 4 of 16 | 0.5 mg | Sep 7, 2026 4d overdue | Overdue |
| Marcus B. | Tirzepatide | Week 14 of 20 | 10 mg | Sep 14, 2026 in 3d | On track |
| Nina K. | Semaglutide | Week 10 of 16 | 1.7 mg | Sep 16, 2026 in 5d | On track |
Security & data
Each clinic sees only its own patients — enforced at the database level, not just the app.
Patient data is encrypted in transit and at rest.
Built to connect with your existing clinical systems via API — without double entry.
SMS-first: nothing extra for patients to install or secure.
Request access and we'll set you up with a live sandbox you can click through today.